Nandrolone

Androgen Receptor Binding — Why 19-Nor Matters#

Nandrolone is testosterone with the C19 methyl group removed. That single structural change is responsible for everything that makes this compound behave differently from test. At the AR itself, nandrolone actually binds slightly harder than testosterone — but the story shifts the moment 5α-reductase gets involved.

"Nandrolone was found to have a higher affinity for the androgen receptor than testosterone but its 5α-dihydro metabolite is a weaker androgen receptor ligand than the parent compound." — Bergink EW, Geelen JAA, Turpijn EW, Acta Endocrinol Suppl, 1985

In muscle — which is low in 5α-reductase — nandrolone stays as nandrolone and drives a strong anabolic signal. That's where the community 8/10 muscle growth score and ~125 anabolic rating come from.

The DHN Advantage in Androgenic Tissue#

In tissues rich in 5α-reductase — scalp, prostate, sebaceous glands — nandrolone converts to 5α-dihydronandrolone (DHN), which is a weaker AR ligand than the parent. This is the mirror image of testosterone, which reduces to the more potent DHT in those same tissues.

"Unlike testosterone, reduction of nandrolone by 5α-reductase yielded a product with markedly lower androgen receptor binding capacity, explaining its relatively low androgenicity in tissues rich in this enzyme." — Tóth M, Zakár T, J Steroid Biochem, 1985

Practical consequence: androgenic sides are lower per-mg than testosterone — less acne, less scalp pressure, less prostate load — which is why nandrolone is a favored base for users with hair concerns. It's also the reason finasteride is counterproductive on a deca cycle: blocking 5α-reductase keeps more nandrolone in its stronger form and can worsen androgenic sides. Topical AR antagonists (RU58841, pyrilutamide) are the right tool for hair on a 19-nor cycle.

Progesterone Receptor Activity — The Prolactin Problem#

Nandrolone and its metabolites have meaningful affinity for the progesterone receptor. This is the mechanistic root of the classic 19-nor sexual side effects — libido crash, erectile dysfunction ("deca dick"), and occasional lactation. PR activation drives prolactin elevation, and prolactin antagonizes dopamine-mediated sexual function.

This is why cabergoline 0.25 mg twice weekly is part of the standard nandrolone toolkit above ~400 mg/wk, and why running nandrolone without an adequate testosterone base is the single most reliable way to wreck your sex drive on cycle.

Low Aromatization, But Not Zero#

Nandrolone aromatizes to estradiol at roughly ~20% the rate of testosterone. Estrogenic load is real but modest — gyno is possible at higher doses, but the bigger practical error is the opposite: crushing E2 with an aggressive AI. Low estrogen on a 19-nor stack is another direct path to sexual dysfunction, because you've now removed both the progesterone-antagonizing effect of E2 and the AR drive from test. Titrate AI to bloods, don't chase a number.

Collagen Synthesis and Joint Relief#

The "deca heals joints" reputation isn't folklore — it has a plausible mechanism. Nandrolone appears to stimulate type I/III collagen synthesis and increase glycosaminoglycan content in articular cartilage, alongside generalized water retention in connective tissue.

"ND appears to increase collagen synthesis and incorporate glycosaminoglycans in articular cartilage, which could explain its protective and therapeutic effects against joint pain reported by users." — Patanè FG, Liberto A, Maglitto ANM, et al., Medicina (Kaunas), 2020

This is the basis for the low-dose joint protocol (100–150 mg/wk on top of TRT) that lifters with chronic elbow, shoulder, or knee tendinopathy run for 12–20 weeks at a time. Users typically report noticeable relief within 2–4 weeks — driven by genuine connective-tissue remodeling rather than just the water cushion, though the fluid component contributes to the "padded" feeling under load.

Depot Pharmacokinetics — Why Deca Ramps Slowly#

Nandrolone base has a short half-life (~4 hours); the ester controls the release profile. Decanoate is the long-chain ester designed to drip nandrolone out of an oil depot over days.

"After an intramuscular administration of 50, 100, or 150 mg ND, serum nandrolone reached its maximum concentration after 72 h and had a terminal elimination half-life of 7–12 days." — Bagchus WM, Smeets JM, Verheul HA, et al., JCEM, 2005

"The plasma elimination half-life of nandrolone phenylpropionate after a single intramuscular injection was measured at approximately 2.5 days, supporting its use for shorter-cycle protocols." — Belkien L, Schürmeyer T, Hano R, Gunnarsson PO, Nieschlag E, J Steroid Biochem, 1985

The 5-week ramp on Deca is why kickstarting with Dbol or Anadrol for the first 4–5 weeks is standard — you need coverage while the depot builds to plateau. It's also why PCT should start 3–4 weeks after the last Deca pin, not the standard 2 weeks used with testosterone enanthate. Start too early and the nandrolone still circulating will shut down the SERM protocol before it can do its job.

Common (most users)#

• Mild water retention / facial fullness. Nandrolone is a "wet" compound and pulls fluid intracellularly and in connective tissue. This is partly why joints feel better. Manage with sodium awareness and adequate potassium; don't reach for an AI to crush it — low E2 on a 19-nor is the fastest route to sexual dysfunction. Accept a few pounds of water as part of the compound's character.
• Libido softening / weaker morning wood. Usually a prolactin creep or E2 drifting out of the sweet spot. First check: is your test dose ≥ your nandrolone dose? If yes, pull a prolactin + E2 panel before adjusting anything. Caber 0.25 mg twice weekly clears it in most cases.
• Mild acne / oily skin. Much less than testosterone at equivalent doses because 5α-reductase converts nandrolone to the weaker DHN metabolite (Bergink et al. 1985; Tóth & Zakár 1985). Standard topical routine — benzoyl peroxide, adapalene — handles it.
• Injection-site soreness (NPP especially). NPP is notoriously "pippy" for some users due to the shorter ester and higher injection frequency. Rotate sites (glute / VG / quad / delt), warm the oil before drawing, and consider dropping concentration to 100 mg/mL if pinning a 200 mg/mL prep feels like a knife.
• Increased appetite. Generally welcomed on a mass cycle. On a recomp, track intake.
• Improved joint comfort (beneficial side effect). Most users report meaningful relief from chronic tendinopathy within 2–4 weeks via increased collagen synthesis and synovial GAG content (Patanè et al. 2020). This is the reason for the low-dose "cruise deca" protocol.

Uncommon (dose-dependent or individual)#

• Prolactin elevation → full sexual dysfunction ("deca dick"). Progestogenic activity of nandrolone raises prolactin in a dose-dependent way. Symptoms: loss of libido, ED, anorgasmia, occasionally nipple discharge. Pull prolactin bloods; run cabergoline 0.25 mg 2×/week (pramipexole as a cheaper alternative). Mandatory prophylaxis above ~400 mg/wk.
• Gynecomastia. Nandrolone aromatizes at roughly ~20% the rate of test, but the progestogenic component can drive gyno even at "normal" E2. If nipples get puffy/itchy on balanced E2, the driver is prolactin — add caber, not more AI.
• Hematocrit climbing past 52%. Standard AAS polycythemia. Donate blood; repeat CBC in 6–8 weeks. Track BP at home.
• Dyslipidemia (↓HDL, ↑LDL). Expected on any AAS, moderate on nandrolone. Cardio 3–4×/week, keep saturated fat modest, consider a low-dose statin or citrus bergamot if lipids drift badly mid-cycle.
• Blood pressure creep. Usually secondary to water retention + hematocrit. Monitor at home; telmisartan 20–40 mg is the community default if BP drifts above 135/85.
• Accelerated hair loss in susceptible users. Lower per-mg than test, but not zero. Do not use finasteride — blocking 5α-reductase keeps nandrolone in its more potent form, worsening scalp activity. Use topical RU58841 or pyrilutamide as AR antagonists, plus topical minoxidil.
• Suppression of endogenous testosterone. Near-total at any meaningful dose. This is not optional — it's the reason the test base is non-negotiable.
• Bloodwork cadence when any of the above appear: CBC, lipid panel, E2 (sensitive), prolactin, total/free T, SHBG. Baseline → week 6 → mid-cycle → end-of-cycle.

Rare but serious#

• Severe depression or mood disturbance. Progestogenic AAS have a stronger association with mood issues than straight testosterone. Warning signs: anhedonia, intrusive thoughts, insomnia unresolved by lowering dose. Stop and run PCT; do not white-knuckle it.
• Cardiomyopathy / LV hypertrophy with long-term high-dose use. This is a cumulative-exposure risk, not a first-cycle risk — but it's why year-round blast cycles are not harmless. An echo every few years is reasonable for long-term users.
• Thromboembolic events. Rare but documented with uncontrolled hematocrit. If HCT >54%, donate and pull back dose; do not ignore it.
• Virilization in any female partner exposed to oil residue / shared sheets — a minor but real concern with deca's long half-life; just be clean about injection hygiene.
• Tendon rupture during the strength-outpaces-connective-tissue window. Ironic given nandrolone's joint benefits, but strength gains can still outrun tendon adaptation on heavy cycles. Don't PR on compromised sleep/recovery.

Hard contraindications#

• Running nandrolone without a testosterone base. Not a preference — this is the textbook cause of sexual dysfunction and depression on deca. Test dose ≥ nandrolone dose, always.
• Finasteride or dutasteride alongside nandrolone. 5α-reductase inhibition keeps nandrolone in its more potent form; you lose the protective DHN conversion that makes nandrolone mild on scalp and prostate in the first place (Bergink 1985).
• Tested sport. 19-norandrosterone metabolites are detectable in urine for up to 6 months after a single injection (Bagchus 2005). Nandrolone is not viable for any tested federation.
• Prostate cancer, breast cancer, untreated hypertension, active dyslipidemia, baseline polycythemia, pregnancy. Absolute contraindications.
• Plans to conceive in the next 12 months. Nandrolone's deep, long HPTA suppression makes fertility recovery slower than with testosterone. Run HCG through cycle and into PCT if fertility matters, and accept a longer recovery window.
• Crushing E2 with an aggressive AI. Not a contraindication to the compound — a contraindication to a protocol pattern. Low E2 + nandrolone is functionally guaranteed sexual dysfunction. Titrate AI to bloods, not to vibes.

Gender and PCT considerations#

Women: Nandrolone is lower-virilization per mg than testosterone but still virilizing, and virilization (voice deepening, clitoromegaly) is permanent. Women who choose to use it run NPP only — 25–50 mg/week for 6–8 weeks maximum — because the long decanoate ester cannot be pulled quickly if sides appear. Stop at the first sign of voice change or clitoral sensitivity.

PCT: Nandrolone's HPTA suppression is deep and its clearance is slow. For decanoate cycles, wait 3–4 weeks after the last pin before starting PCT — starting SERMs while nandrolone is still circulating is how people end up with a failed PCT and three months of low-T limbo. Standard protocol: HCG 500–1000 IU 2×/week for the final 2–3 weeks before PCT start (or run through cycle), then nolvadex 40/40/20/20 + clomid 50/50/25/25. NPP shortens the wait to ~2 weeks post-last-pin. Bloods at 6 and 12 weeks post-PCT to confirm recovery — if total T hasn't cleared 400 ng/dL by 12 weeks, extend.